Becton Dickinson is validating the company's test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
"AMBS" - Read the recent Yahoo news.
The co-founder of Amgen and the former head of M & A for Novartis are two of the members of the company's advisory board.
The company is in a development deal with Becton Dickinson for its diagnostic test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
The company's pateneted MANF drug already has two "orphan indications" with many more expected to follow.
Follow the company on Twitter: @AmarantusBio ..... 8,480 followers
Visit the company's website to see who's on the company's advisory board.
One of the co-founders of Amgen and the former head of M & A for Novartis are two of the members.
It's possible but I think "AMBS" is likely to partner with Novartis or Becton Dickinson before a buyout would occur.
AMBS - The next Amgen?
Buy a few shares today and hold them for six months.
Follow the company on Twitter: @AmarantusBio .... 8,480 followers
p.s. Consider GSS below .45. :(
You would consider buying or partnering with Amarantus Bioscience: "AMBS"
The company's patented MANF drug could be worth billions.
Interesting weeks ahead.
Sierra World is a joke.
Read the sites disclaimer that says it's for entertainment purposes only and that the individuals posting are fictional characters and that the information posted may not be factual.
p.s. Better info from bathroom walls.
If what Sierra World has posted in the past had any credibility Amarantus would already been bought by Pfizer or Eli Lilly or Amgen or have finalized three or four other partnerships.
"This post is for entertainment purposes only. The writer may be a fictional character or not."
The penny flippers, and the shorts under estimate the impact that future p.r.'s will have on the share price.
The company currently has 8,472 followers on Twitter: @AmarantusBio
The average Twitter user has 126 followers. If every AMBS followers retweeted the news from AMBS it would reach almost 1,000,000 individuals. That's a best case scenario but I think you get my point.
It's also substantially easier for a retail investor to buy a penny stock than to short it.
Welcome to the age of social media.
p.s. Re-tweet the company's news to your Twitter followers. Let them know about the tremendous opportunities that Gerald is pursuing.